Mingjiang Xu

Professor, Molecular Medicine

Phone+1-305-338-0506
Emailxum1@uthscsa.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Mingjiang Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5313 Citations
39 h-Index
95 Article
6 Review article
5 Letter
4 Comment/debate

HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
Zhu, G., Luo, H., Feng, Y., Guryanova, O. A., Xu, J., Chen, S., Lai, Q., Sharma, A., Xu, B., Zhao, Z., Feng, R., Ni, H., Claxton, D., Guo, Y., Mesa, R. A., Qiu, Y., Yang, F. C., Li, W., Nimer, S. D., Huang, S. & 1 others, Xu, M., Dec 2021, In: Nature communications. 12, 1, 1956.
Research output: Contribution to journal › Article › peer-review

Open Access
Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
Wang, J., Miao, Z., Jiang, Y., Zou, P., Li, W., Tang, X., Lv, Y., Xing, D., Chen, S., Yang, F., Xu, M., Cao, Z., Wang, H. & Zhao, Z., Jun 1 2020, In: Oncology Letters. 19, 6, p. 3789-3798 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency (Oncology Letters (2020) 19 (3789-3798) DOI: 10.3892/ol.2020.11479)
Wang, J., Miao, Z., Jiang, Y., Zou, P., Li, W., Tang, X., Lv, Y., Xing, D., Chen, S., Yang, F., Xu, M., Cao, Z., Wang, H. & Zhao, Z., Oct 2020, In: Oncology Letters. 20, 4, e11907.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G. & Zhou, D., Jul 27 2020, In: Journal of Hematology and Oncology. 13, 1, 103.
Research output: Contribution to journal › Review article › peer-review

Open Access
5 Scopus citations
The Role of ASXL1/2 and Their Associated Proteins in Malignant Hematopoiesis
Zhang, P., Xu, M. & Yang, F. C., Mar 1 2020, In: Current Stem Cell Reports. 6, 1, p. 6-15 10 p.
Research output: Contribution to journal › Review article › peer-review

UT Health San Antonio: Dr. Mingjiang Xu receives UT System award to support cancer epigenetics research
Mingjiang Xu
10/9/20
1 item of Media coverage
Press/Media: Press / Media
S.A.’s Mays Cancer Center gets $10.3M in state funding
Luiz O Penalva, Dmitri N Ivanov, Mingjiang Xu & Ruben Mesa
8/28/20
2 items of Media coverage
Press/Media: Press / Media
University of Texas Health Science Center at San Antonio: CPRIT Awards Mays Cancer Center More Than $10.3 Million
Raushan T Kurmasheva, Luiz O Penalva, Dmitri N Ivanov, Manjeet K Rao, Mingjiang Xu & Ruben Mesa
8/21/20
1 item of Media coverage
Press/Media: Press / Media
These SA institutions to get over $10M in cancer research funding
Luiz O Penalva & Mingjiang Xu
8/19/20
2 items of Media coverage
Press/Media: Press / Media
LEUKEMIA AND LYMPHOMA SOCIETY AWARDS PRESTIGIOUS GRANT TO SYLVESTER TO ACCELERATE EPIGENETIC RESEARCH
Mingjiang Xu
11/20/17
1 item of Media coverage
Press/Media: Press / Media